Bayer to present latest research across its advancing oncology portfolio at AACR 2023 Annual Meeting
The Pharma Data
APRIL 11, 2023
The presentation highlights the synergistic anti-cancer effects of a PSMA (prostate-specific membrane antigen)-actinium-225 conjugate in combination with darolutamide in preclinical prostate cancer models. Data from all three areas of scientific focus will be showcased during this year’s meeting.
Let's personalize your content